These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19058360)

  • 1. [Resistance of uropathogens and outcomes of antibacterial therapy of urinary infections].
    Rafal'skiĭ VV; Khodnevich LV
    Urologiia; 2008; (4):3-4, 6-9. PubMed ID: 19058360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of resistant uropathogens in ambulatory urinary tract infections in women.
    Cunha BA
    Scand J Infect Dis; 2006; 38(3):235-6. PubMed ID: 16500792
    [No Abstract]   [Full Text] [Related]  

  • 3. Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005.
    Wagenlehner FM; Niemetz AH; Weidner W; Naber KG
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S25-34. PubMed ID: 17997282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].
    Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV
    Urologiia; 2009; (3):18-21. PubMed ID: 19670810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Choice of antibacterial drugs in urinary infection].
    Perepanova TS; Kozlov RS; Dekhnich AV; Palagin IS; Shevelev AN; Volkova EM; Égamberdiev DK
    Urologiia; 2012; (2):4-8. PubMed ID: 22876623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the treatment of urinary tract infection.
    Tolkoff-Rubin NE; Rubin RH
    Am J Med; 1987 Apr; 82(4A):270-7. PubMed ID: 3555047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary tract infections--what is new?].
    Wańikowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):103-9. PubMed ID: 15603316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for bacterial urinary tract infections.
    Wagenlehner FM; Weidner W; Naber KG
    Expert Opin Emerg Drugs; 2005 May; 10(2):275-98. PubMed ID: 15934867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
    Ruxer J; Mozdzan M; Loba J; Markuszewski L
    Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rational antibiotic therapy of urinary tract infections].
    Wagenlehner FM; Naber KG; Weidner W
    Med Monatsschr Pharm; 2008 Oct; 31(10):385-90; quiz 391-2. PubMed ID: 18972869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing resistance of uropathogens to antibiotics.
    Leibovici L; Tarchizky D; Wysenbeek AJ
    Isr J Med Sci; 1985 Jul; 21(7):627-8. PubMed ID: 4044224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of nitrofurantoin in the treatment of chronic urinary tract infections in patients with type 2 diabetes mellitus].
    Mozdzan M; Ruxer J; Siejka A; Loba J; Markuszewski L
    Pol Merkur Lekarski; 2006 Nov; 21(125):434-8. PubMed ID: 17345835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical treatment for pediatric urinary tract infection and resistance patterns of uropathogens, in Queen Alia hospital and prince A'Isha military center--Jordan.
    Al-Mardeni RI; Batarseh A; Omaish L; Shraideh M; Batarseh B; Unis N
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):135-9. PubMed ID: 19112236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?
    Miller LG; Mehrotra R; Tang AW
    Int J Antimicrob Agents; 2007 May; 29(5):605-7. PubMed ID: 17293087
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue.
    Wisell KT; Kahlmeter G; Giske CG
    J Antimicrob Chemother; 2008 Jul; 62(1):35-40. PubMed ID: 18408238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
    Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
    Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant gram-negative uropathogens: A review.
    Khoshnood S; Heidary M; Mirnejad R; Bahramian A; Sedighi M; Mirzaei H
    Biomed Pharmacother; 2017 Oct; 94():982-994. PubMed ID: 28810536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
    Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
    Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.